Title of article :
Selective Antibody Deficiency and its Relation to the IgG2 and IgG3 Subclass Titers in Recurrent Respiratory Infections
Author/Authors :
Sherkat, Roya Infectious Diseases and Tropical Medicine Research Center - Isfahan University of Medical Sciences - Isfahan , Shoaei, Parisa Infectious Diseases and Tropical Medicine Research Center - Isfahan University of Medical Sciences - Isfahan , Kassaian, Nazila Infectious Diseases and Tropical Medicine Research Center - Isfahan University of Medical Sciences - Isfahan , Parvaneh, Nima Department of Pediatrics - Tehran University of Medical Sciences - Tehran , Babak, Anahita Community and Preventive Medicine Specialist - Isfahan University of Medical Sciences - Isfahan
Abstract :
Background: Selective antibody deficiency with normal immunoglobulins (SADNI)
may be identified as part of distinct primary or secondary immunodeficiency disorders.
The clinical manifestations include recurrent, often severe or prolonged, upper or lower
respiratory tract infections. Objectives: To evaluate SADNI in patients with recurrent
sinopulmonary infections and its relation to IgG subclass deficiencies. Methods: In a
case-control study, anti-pneumococcal antibody titer and IgG2, IgG3 levels before injection
of pneumococcal vaccine and anti-pneumococcal antibody titer at least 4 weeks
the vaccination were measured in 46 patients and 54 controls. The results were compared
using student's t-test. Results: There was a significant correlation between age
and anti-pneumococcal antibody titers before and after vaccination in patients. No significant
relation was found between pre and post vaccination pneumococcal antibody
titer and IgG2 and IgG3 in cases and controls (p>0.05). The mean of anti-pneumococcal
antibody before and after vaccination were significantly different in cases and controls
and were higher in control group (p=0.01, p=0.001, respectively). Anti-pneumococcal
antibody titers in 97.8% of cases and 100% of controls group were normal (>3.4 μg/ml).
34.8% of cases and 9.1% of controls had low titers of anti-pneumococcal antibody (<20
μg/ml) while 18.7% of cases and no controls failed to respond to vaccine. Conclusion:
Evaluation of anti-pneumococcal antibody titer in patients with recurrent, chronic and
severe respiratory infections with normal immunoglobulin levels seems to be necessary
as early diagnosis. Treatment of such a cases could prevent later sequelae such as mastoiditis
and bronchiecstasia.
Keywords :
Antibody Deficiency , Respiratory Tract Infection , Streptococcus Pneumoniae
Journal title :
Astroparticle Physics